Back to funds
View filing
Propel Bio Management, LLC
hedge fundUpdated 31 days agoManaged by Propel Bio Management, Llc • Latest filing Q2 2026
Portfolio value
$191.1M
Q2 2026
Filings
11
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
-1.5%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 11 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2023 | $120.6M |
| Q1 2024 | $171.8M |
| Q2 2024 | $154.2M |
| Q3 2024 | $172.4M |
| Q4 2024 | $100.7M |
| Q1 2025 | $86.1M |
| Q2 2025 | $82.4M |
| Q3 2025 | $99.9M |
| Q4 2025 | $117.1M |
| Q1 2026 | $158.7M |
| Q2 2026 | $191.1M |
Top holdings
29 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | P PAGP PLAINS GP HOLDINGS LP-CL | $30.9M | 1.27M | 16.16% | — |
| 2 | A ACHV ACHIEVE LIFE SCIENCES INC | $26.3M | 4.03M | 13.79% | — |
| 3 | C CORT CORCEPT THERAPEUTICS INC | $11.9M | 136.5K | 6.21% | — |
| 4 | P PHAT PHATHOM PHARMACEUTICALS I | $11.4M | 1.05M | 5.96% | — |
| 5 | D DCTH DELCATH SYSTEMS INC | $11M | 871.5K | 5.74% | — |
| 6 | M MIST MILESTONE PHARMACEUTICALS | $10M | 7.43M | 5.21% | — |
| 7 | C CMPS COMPASS PATHWAYS PLC | $8.1M | 573.1K | 4.24% | — |
| 8 | ? N/A KYVERNA THERAPEUTICS INC | $7.9M | 883.2K | 4.12% | — |
| 9 | ? N/A ARTIVA BIOTHERAPEUTICS IN | $6.8M | 696.4K | 3.54% | — |
| 10 | A ABEO ABEONA THERAPEUTICS INC | $6.1M | 983.1K | 3.18% | — |
| 11 | A AQST AQUESTIVE THERAPEUTICS IN | $6M | 1.44M | 3.14% | — |
| 12 | ? N/A PALISADE BIO INC | $5.4M | 2.58M | 2.82% | — |
| 13 | ? N/A IMMUNIC INC | $5M | 325.0K | 2.61% | — |
| 14 | I IVEVF INVENTIVA SA - ADR | $4.8M | 1.28M | 2.53% | — |
| 15 | S SABSW SAB BIOTHERAPEUTICS INC | $4.2M | 1.08M | 2.20% | — |
| 16 | O OBIO ORCHESTRA BIOMED HOLDINGS | $3.9M | 896.7K | 2.02% | — |
| 17 | C CLDX CELLDEX THERAPEUTICS INC | $3.9M | 103.7K | 2.02% | — |
| 18 | J JPM-PM ZEVRA THERAPEUTICS INC | $3.6M | 253.5K | 1.90% | — |
| 19 | O OCFC OCULAR THERAPEUTIX INC | $3.5M | 358.0K | 1.84% | — |
| 20 | F FDMT 4D MOLECULAR THERAPEUTICS IN | $3.4M | 252.7K | 1.76% | — |